메뉴 건너뛰기




Volumn 24, Issue , 2011, Pages 69-78

Specific Immunotherapy in Children: The Evidence

Author keywords

allergy; Specific immunotherapy; subcutaneous immunotherapy

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

EID: 84856402169     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/03946320110240S413     Document Type: Article
Times cited : (43)

References (93)
  • 1
    • 50249230114 scopus 로고
    • Prophylactic inoculation against hay-fever
    • Noon J,. Prophylactic inoculation against hay-fever. Lancet 1911; i: 1572.
    • (1911) Lancet , vol.1 , pp. 1572
    • Noon, J.1
  • 2
    • 0031817107 scopus 로고    scopus 로고
    • Allergen immunotherapy: Therapeutical vaccines for allergic diseases
    • World Health Organisation Position Paper
    • World Health Organisation Position Paper. Allergen immunotherapy: Therapeutical vaccines for allergic diseases. Bousquet J, Lockey R, Mailing HJ, edts. Allergy 1998; 53 (suppl 72): 3-13.
    • (1998) Allergy , vol.53 , pp. 3-13
    • Bousquet, J.1    Lockey, R.2    Mailing, H.J.3
  • 3
    • 0036828311 scopus 로고    scopus 로고
    • The link between allergic rhinitis and allergic asthma: A prospective population-based study. the Copenhagen Allergy Study
    • Linneberg A, Henrik NN, Frolund L, et al. The link between allergic rhinitis and allergic asthma: A prospective population-based study. The Copenhagen Allergy Study. Allergy 2002; 57: 1048-1052.
    • (2002) Allergy , vol.57 , pp. 1048-1052
    • Linneberg, A.1    Henrik, N.N.2    Frolund, L.3
  • 4
    • 34948867286 scopus 로고    scopus 로고
    • Childhood allergic rhinitis predicts asthma incidence and persistence to middle age. A longitudinal study
    • Burgess JA, Walters EH, Byrnes GB, Matheson MC, Jenkins MA, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age. A longitudinal study. J Allergy Clin Immunol, 2007, 120: 863-870
    • (2007) J Allergy Clin Immunol , vol.120 , pp. 863-870
    • Burgess, J.A.1    Walters, E.H.2    Byrnes, G.B.3    Matheson, M.C.4    Jenkins, M.A.5
  • 5
    • 33646480059 scopus 로고    scopus 로고
    • Intermittent inhaled corticosteroids in infants with episodic wheezing
    • Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006; 354: 1998-2005.
    • (2006) N Engl J Med , vol.354 , pp. 1998-2005
    • Bisgaard, H.1    Hermansen, M.N.2    Loland, L.3
  • 6
    • 33747758047 scopus 로고    scopus 로고
    • Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): Double-blind, randomised, controlled study
    • Murray CS, Woodcock A, Langley SJ, et al. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): Double-blind, randomised, controlled study. Lancet 2006; 368: 754-762.
    • (2006) Lancet , vol.368 , pp. 754-762
    • Murray, C.S.1    Woodcock, A.2    Langley, S.J.3
  • 7
    • 33646488054 scopus 로고    scopus 로고
    • Long-term inhaled corticosteroids in preschool children at high risk for asthma
    • Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985-1997.
    • (2006) N Engl J Med , vol.354 , pp. 1985-1997
    • Guilbert, T.W.1    Morgan, W.J.2    Zeiger, R.S.3
  • 8
    • 59449104525 scopus 로고    scopus 로고
    • Specific immunotherapy for respiratory allergy: State of the art according to current meta-analyses
    • Jan
    • Compalati E, Penagos M, Tarantini F, Passalacqua G, Canonica GW,. Specific immunotherapy for respiratory allergy: State of the art according to current meta-analyses. Ann Allergy Asthma Immunol. 2009 Jan; 102 (1): 22-8.
    • (2009) Ann Allergy Asthma Immunol , vol.102 , Issue.1 , pp. 22-28
    • Compalati, E.1    Penagos, M.2    Tarantini, F.3    Passalacqua, G.4    Canonica, G.W.5
  • 9
    • 0014360634 scopus 로고
    • The value of hyposensitization therapy for bronchial asthma in children. A 14-year study
    • Johnston DE, Dutton A,: The value of hyposensitization therapy for bronchial asthma in children. A 14-year study. Pediatrics, 1968; 42: 793-802.
    • (1968) Pediatrics , vol.42 , pp. 793-802
    • Johnston, D.E.1    Dutton, A.2
  • 10
    • 0036170801 scopus 로고    scopus 로고
    • Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)
    • Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109: 251-256.
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 251-256
    • Moller, C.1    Dreborg, S.2    Ferdousi, H.A.3    Halken, S.4    Host, A.5    Jacobsen, L.6
  • 11
    • 33745128688 scopus 로고    scopus 로고
    • Five-year follow-up on the PAT study: Specific immunotherapy and long-term prevention of asthma in children
    • Niggemann B, Jacobsen L, Dreborg S.H.A., Ferdousi HA, Halkens, et al. Five-year follow-up on the PAT study: Specific immunotherapy and long-term prevention of asthma in children. Allergy 2006, 61; 855: 859.
    • (2006) Allergy , vol.61 , pp. 855-859
    • Niggemann, B.1    Jacobsen, L.2    Dreborg, S.H.A.3    Ferdousi, H.A.4    Halkens5
  • 12
    • 34447132918 scopus 로고    scopus 로고
    • Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study
    • (The PAT investigator group)
    • Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, et al.(The PAT investigator group). Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007; 62 (8): 943-8.
    • (2007) Allergy , vol.62 , Issue.8 , pp. 943-948
    • Jacobsen, L.1    Niggemann, B.2    Dreborg, S.3    Ferdousi, H.A.4    Halken, S.5
  • 13
    • 4944266011 scopus 로고    scopus 로고
    • Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis
    • Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114: 851-857.
    • (2004) J Allergy Clin Immunol , vol.114 , pp. 851-857
    • Novembre, E.1    Galli, E.2    Landi, F.3    Caffarelli, C.4    Pifferi, M.5    De Marco, E.6
  • 14
    • 0030903223 scopus 로고    scopus 로고
    • Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children
    • Des Roches AD, Paradis L, Menardo JL, Bouges S, Daur JP Jean-Pierre, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-3.
    • (1997) J Allergy Clin Immunol , vol.99 , pp. 450-453
    • Des Roches, A.D.1    Paradis, L.2    Menardo, J.L.3    Bouges, S.4    Daur, J.P.J.-P.5
  • 15
    • 0034847103 scopus 로고    scopus 로고
    • Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study
    • Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S,. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy, 2001, 31: 1392-1397.
    • (2001) Clin Exp Allergy , vol.31 , pp. 1392-1397
    • Pajno, G.B.1    Barberio, G.2    De Luca, F.3    Morabito, L.4    Parmiani, S.5
  • 16
    • 0032854220 scopus 로고    scopus 로고
    • Sublingual immunotherapy: A double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both
    • Purello-D'Ambrosio F, Gangemi S, Isola S, La Motta N, Puccinelli P, Parmiani S, et al. Sublingual immunotherapy: A double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both. Allergy 1999; 54: 968-973.
    • (1999) Allergy , vol.54 , pp. 968-973
    • Purello-D'Ambrosio, F.1    Gangemi, S.2    Isola, S.3    La Motta, N.4    Puccinelli, P.5    Parmiani, S.6
  • 20
    • 34250691985 scopus 로고    scopus 로고
    • Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France
    • Omnes LF, Bousquet J, Scheinmann P, et al. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France. Eur Ann Allergy Clin Immunol 2007; 39: 148-56.
    • (2007) Eur Ann Allergy Clin Immunol , vol.39 , pp. 148-156
    • Omnes, L.F.1    Bousquet, J.2    Scheinmann, P.3
  • 21
    • 43449109478 scopus 로고    scopus 로고
    • Economic evaluation of sublingual vs subcutaneous allergen immunotherapy
    • Podladnikova J, Krcmova I, Vlcek J,. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 2008; 100; 482-9.
    • (2008) Ann Allergy Asthma Immunol , vol.100 , pp. 482-489
    • Podladnikova, J.1    Krcmova, I.2    Vlcek, J.3
  • 23
    • 0035253346 scopus 로고    scopus 로고
    • Th type-1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism
    • Tang C, Inman MD, van Rooijen N, et al.Th type-1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001; 166: 1471-81
    • (2001) J Immunol , vol.166 , pp. 1471-1481
    • Tang, C.1    Inman, M.D.2    Van Rooijen, N.3
  • 24
    • 0030003889 scopus 로고    scopus 로고
    • Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma
    • Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996; 97: 1356-65
    • (1996) J Allergy Clin Immunol , vol.97 , pp. 1356-1365
    • Durham, S.R.1    Ying, S.2    Varney, V.A.3    Jacobson, M.R.4    Sudderick, R.M.5    Mackay, I.S.6
  • 25
    • 0035016912 scopus 로고    scopus 로고
    • Grass pollen immunotherapy: Symptomatic improvement correlates with reduction in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season
    • Wilson DR, Nouri-Aria KT, Walker SM, Pajno GB, O'Brien F, Jacobson MR, et al. Grass pollen immunotherapy: Symptomatic improvement correlates with reduction in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001; 107: 971-6
    • (2001) J Allergy Clin Immunol , vol.107 , pp. 971-976
    • Wilson, D.R.1    Nouri-Aria, K.T.2    Walker, S.M.3    Pajno, G.B.4    O'Brien, F.5    Jacobson, M.R.6
  • 26
    • 1642290976 scopus 로고    scopus 로고
    • Bacillus Calmette-guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy
    • Arikan C, Bahceciler NN, Deniz G, Akdis M, Akkoc T, Akdis CA, et al. Bacillus Calmette-guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 2004; 34: 398-405
    • (2004) Clin Exp Allergy , vol.34 , pp. 398-405
    • Arikan, C.1    Bahceciler, N.N.2    Deniz, G.3    Akdis, M.4    Akkoc, T.5    Akdis, C.A.6
  • 27
    • 33644746130 scopus 로고    scopus 로고
    • Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin e and increases both interferon- and interleukin-10-production
    • Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon- and interleukin-10-production. Clin Exp Allergy 2006; 36: 261-72
    • (2006) Clin Exp Allergy , vol.36 , pp. 261-272
    • Cosmi, L.1    Santarlasci, V.2    Angeli, R.3    Liotta, F.4    Maggi, L.5    Frosali, F.6
  • 29
    • 0038363534 scopus 로고    scopus 로고
    • IL10 and TGFbeta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
    • Jutel M, Akdis M, Budak F, et al. IL10 and TGFbeta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-14
    • (2003) Eur J Immunol , vol.33 , pp. 1205-1214
    • Jutel, M.1    Akdis, M.2    Budak, F.3
  • 30
    • 0037504093 scopus 로고    scopus 로고
    • Induction of IL10+CD4+CD25+ T cells by grass pollen immunotherapy
    • Francis JN, Till SJ, Durham SR, Induction of IL10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111: 1255-61
    • (2003) J Allergy Clin Immunol , vol.111 , pp. 1255-1261
    • Francis, J.N.1    Till, S.J.2    Durham, S.R.3
  • 31
    • 1642403034 scopus 로고    scopus 로고
    • Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy
    • Savolainen J, Laaksonen K, Rantio-Lehtimaki A, Terho EO, Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy 2004; 34: 413-9
    • (2004) Clin Exp Allergy , vol.34 , pp. 413-419
    • Savolainen, J.1    Laaksonen, K.2    Rantio-Lehtimaki, A.3    Terho, E.O.4
  • 32
    • 1642344677 scopus 로고    scopus 로고
    • Interleukin-10, T regulatory cells and specific allergy treatment
    • Blaser K, Akdis CA, Interleukin-10, T regulatory cells and specific allergy treatment. Clin Exp Allergy 2004; 34: 328-31
    • (2004) Clin Exp Allergy , vol.34 , pp. 328-331
    • Blaser, K.1    Akdis, C.A.2
  • 33
    • 1342308180 scopus 로고    scopus 로고
    • Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease
    • Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 608-15
    • (2004) Lancet , vol.363 , pp. 608-615
    • Ling, E.M.1    Smith, T.2    Nguyen, X.D.3
  • 35
    • 33748294181 scopus 로고    scopus 로고
    • Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC
    • Savolainen J, Jacobsen L, Valovirta E,. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006; 61: 1184-90
    • (2006) Allergy , vol.61 , pp. 1184-1190
    • Savolainen, J.1    Jacobsen, L.2    Valovirta, E.3
  • 37
    • 33744758057 scopus 로고    scopus 로고
    • Sublingual immunotherapy: Efficacy-methodology and outcome of clinical trials
    • Mailing HJ,. Sublingual immunotherapy: Efficacy-methodology and outcome of clinical trials. Allergy 2006; 61: 24-28
    • (2006) Allergy , vol.61 , pp. 24-28
    • Mailing, H.J.1
  • 39
    • 33745117912 scopus 로고    scopus 로고
    • Mechanism of allergen specific immunotherapy - T cell tolerance and more
    • Jutel M, Akdis M, Blaser K, Akdis CA,. Mechanism of allergen specific immunotherapy-T cell tolerance and more. Allergy 2006; 61: 796-807
    • (2006) Allergy , vol.61 , pp. 796-807
    • Jutel, M.1    Akdis, M.2    Blaser, K.3    Akdis, C.A.4
  • 40
    • 34047161743 scopus 로고    scopus 로고
    • Allergic rhinitis and its impact on asthma update: Allergen immunotherapy
    • Passalacqua G, Durham SR,. Allergic rhinitis and its impact on asthma update: Allergen immunotherapy. J Allergy Clin Immunol 2007; 119: 881-91
    • (2007) J Allergy Clin Immunol , vol.119 , pp. 881-891
    • Passalacqua, G.1    Durham, S.R.2
  • 41
    • 16444365595 scopus 로고    scopus 로고
    • Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites
    • Bahceciler NN, Ariken C, Taylor A, Akdis M, Blaser K, Barlan IB, et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites. Int Arch Allergy Immunol 2005; 136: 287-94
    • (2005) Int Arch Allergy Immunol , vol.136 , pp. 287-294
    • Bahceciler, N.N.1    Ariken, C.2    Taylor, A.3    Akdis, M.4    Blaser, K.5    Barlan, I.B.6
  • 42
    • 26244462106 scopus 로고    scopus 로고
    • Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy
    • Marcucci F, Sensi L, Di Cara G, Salvatori S, Bernini M, Pecora S, et al. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy. Pediatr Allergy Immunol 2005; 16: 519-26
    • (2005) Pediatr Allergy Immunol , vol.16 , pp. 519-526
    • Marcucci, F.1    Sensi, L.2    Di Cara, G.3    Salvatori, S.4    Bernini, M.5    Pecora, S.6
  • 43
    • 0032757566 scopus 로고    scopus 로고
    • Systemic immunological changes induced by administartion of grass pollen allergens via the oral mucosa during sublingual immunotherapy
    • Fanta C, Bohle B, Hirt W, et al. Systemic immunological changes induced by administartion of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999; 120. 218-24
    • (1999) Int Arch Allergy Immunol , vol.120 , pp. 218-224
    • Fanta, C.1    Bohle, B.2    Hirt, W.3
  • 44
    • 0037833502 scopus 로고    scopus 로고
    • Immunomodulation during sublingual therapy in allergic children
    • Ippoliti F, De Santis W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003; 14: 216-21
    • (2003) Pediatr Allergy Immunol , vol.14 , pp. 216-221
    • Ippoliti, F.1    De Santis, W.2    Volterrani, A.3
  • 45
    • 33645033082 scopus 로고    scopus 로고
    • Absence of systemic immunologic changes during dose buil-up phase and early maintenance period in effective specific sublingual immunotherapy in children
    • Dehlink E, Eiwegger T, Gerstmayr M, Kampi E, Bohle B, Chen KW, et al. Absence of systemic immunologic changes during dose buil-up phase and early maintenance period in effective specific sublingual immunotherapy in children. Clin Exp Allergy 2006; 36: 32-9
    • (2006) Clin Exp Allergy , vol.36 , pp. 32-39
    • Dehlink, E.1    Eiwegger, T.2    Gerstmayr, M.3    Kampi, E.4    Bohle, B.5    Chen, K.W.6
  • 46
    • 0026779263 scopus 로고
    • Systemic reactions from allergen immunotherapy
    • Stewart GE, Lockey RF,. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol. 1992; 90: 567-578.
    • (1992) J Allergy Clin Immunol , vol.90 , pp. 567-578
    • Stewart, G.E.1    Lockey, R.F.2
  • 48
    • 84973587700 scopus 로고
    • CSM update. Desensitizing vaccines
    • Committee on the safety of medicines
    • Committee on the safety of medicines. CSM update. Desensitizing vaccines. Br Med J 1986; 293: 948.
    • (1986) Br Med J , vol.293 , pp. 948
  • 50
    • 21444452818 scopus 로고    scopus 로고
    • ARIA Allergie Rhinits and its Impact on Asthma
    • ARIA Allergie Rhinits and its Impact on Asthma. Bousquet J, Van Cauwenberge P, eds. J Allergy Clin Immunol 2001; 108 (suppl 5): S146-S150.
    • (2001) J Allergy Clin Immunol , vol.108 , pp. S146-S150
    • Bousquet, J.1    Van Cauwenberge, P.2
  • 51
    • 0038636186 scopus 로고    scopus 로고
    • A model for management of sublingual immunotherapy
    • Frati F, Sensi L, Di Rienzo V, et al. A model for management of sublingual immunotherapy. Allerg Immunol (Paris) 2003; 35: 56-60.
    • (2003) Allerg Immunol (Paris) , vol.35 , pp. 56-60
    • Frati, F.1    Sensi, L.2    Di Rienzo, V.3
  • 53
  • 54
    • 20044393372 scopus 로고    scopus 로고
    • Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years
    • Di Rienzo V, Minelli M, Musarra A, et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy. 2005; 35: 560-564.
    • (2005) Clin Exp Allergy , vol.35 , pp. 560-564
    • Di Rienzo, V.1    Minelli, M.2    Musarra, A.3
  • 55
    • 20044396240 scopus 로고    scopus 로고
    • The safety of sublingual-swallow immunotherapy: An analysis of published studies
    • Gidaro GB, Frati F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: An analysis of published studies. Clin Exp Allergy. 2005; 35: 565-571.
    • (2005) Clin Exp Allergy , vol.35 , pp. 565-571
    • Gidaro, G.B.1    Frati, F.2    Sensi, L.3
  • 56
    • 0027467542 scopus 로고
    • Controlled dose-response study of immunotherapy with standardized, partially purified extracts of house dust mite: Clinical efficacy and side effects
    • Haugaard L, Dahl R, Jacobsen L A,. Controlled dose-response study of immunotherapy with standardized, partially purified extracts of house dust mite: Clinical efficacy and side effects. J Allergy Clin Immunol 1993; 91: 709-22.
    • (1993) J Allergy Clin Immunol , vol.91 , pp. 709-722
    • Haugaard, L.1    Dahl, R.2    Jacobsen, L.A.3
  • 57
    • 34047179902 scopus 로고    scopus 로고
    • Allergen immunotherapy: Where is it now?
    • Nelson HS, Allergen immunotherapy: Where is it now? J Allergy Clin Immunol 2007; 119: 769-77.
    • (2007) J Allergy Clin Immunol , vol.119 , pp. 769-777
    • Nelson, H.S.1
  • 60
    • 33846939850 scopus 로고    scopus 로고
    • Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures
    • Pham-Ti N, Scheinmann P, Fadel R, et al. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol 2007; 18; 47-57.
    • (2007) Pediatr Allergy Immunol , vol.18 , pp. 47-57
    • Pham-Ti, N.1    Scheinmann, P.2    Fadel, R.3
  • 61
    • 0037833502 scopus 로고    scopus 로고
    • Immunomodulation during sublingual therapy in allergic children
    • Ippoliti F, De Santis W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children. Pediatr. Allergy Immunol. 2003, 14, 216-21
    • (2003) Pediatr. Allergy Immunol , vol.14 , pp. 216-221
    • Ippoliti, F.1    De Santis, W.2    Volterrani, A.3
  • 62
    • 2342534414 scopus 로고    scopus 로고
    • Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: A double blind, placebo-controlled study
    • Bufe A, Ziegler-Kirbach E, Stoeckmann E, et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: A double blind, placebo-controlled study. Allergy 2004; 59: 498-504.
    • (2004) Allergy , vol.59 , pp. 498-504
    • Bufe, A.1    Ziegler-Kirbach, E.2    Stoeckmann, E.3
  • 63
    • 33748302777 scopus 로고    scopus 로고
    • Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children
    • Valovirta E, Jacobsen L, Ljorring C, et al. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006; 61: 1177-83.
    • (2006) Allergy , vol.61 , pp. 1177-1183
    • Valovirta, E.1    Jacobsen, L.2    Ljorring, C.3
  • 64
    • 33646017678 scopus 로고    scopus 로고
    • Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis
    • Durham S, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 802-9.
    • (2006) J Allergy Clin Immunol , vol.117 , pp. 802-809
    • Durham, S.1    Yang, W.H.2    Pedersen, M.R.3
  • 65
    • 36248986032 scopus 로고    scopus 로고
    • Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis
    • Didier A, Mailing H-J, Worm M, et al.Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 120: 1338-45.
    • (2007) J Allergy Clin Immunol , vol.120 , pp. 1338-1345
    • Didier, A.1    Mailing, H.-J.2    Worm, M.3
  • 66
    • 34249904416 scopus 로고    scopus 로고
    • Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis
    • Tahamiler R, Saritzali G, Canakcioglu S,. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope 2007; 117: 965-9.
    • (2007) Laryngoscope , vol.117 , pp. 965-969
    • Tahamiler, R.1    Saritzali, G.2    Canakcioglu, S.3
  • 67
    • 0033773546 scopus 로고    scopus 로고
    • Preseasonal local allergoid immunotherapy to grass pollen in children: A double-blind, placebo-controlled, randomized trial
    • Caffarelli C., Sensi LG, Marcucci F, et al. Preseasonal local allergoid immunotherapy to grass pollen in children: A double-blind, placebo-controlled, randomized trial. Allergy 2000; 55: 1142-7.
    • (2000) Allergy , vol.55 , pp. 1142-1147
    • Caffarelli, C.1    Sensi, L.G.2    Marcucci, F.3
  • 68
    • 0242642190 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen
    • Wuthrich B, Bucher CH, Jorg W, et al. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol 2003; 13: 145-8.
    • (2003) J Investig Allergol Clin Immunol , vol.13 , pp. 145-148
    • Wuthrich, B.1    Bucher, C.H.2    Jorg, W.3
  • 69
    • 8644283471 scopus 로고    scopus 로고
    • A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen
    • Rolinck-Werninghaus C, Wolf H, Liebke C, et al.A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004; 59: 1285-93.
    • (2004) Allergy , vol.59 , pp. 1285-1293
    • Rolinck-Werninghaus, C.1    Wolf, H.2    Liebke, C.3
  • 70
    • 34047164409 scopus 로고    scopus 로고
    • Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care
    • Roder E, Berger MY, Hop WC, et al. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol. 2007; 119: 892-8.
    • (2007) J Allergy Clin Immunol , vol.119 , pp. 892-898
    • Roder, E.1    Berger, M.Y.2    Hop, W.C.3
  • 73
    • 0034112050 scopus 로고    scopus 로고
    • Safety of sublingual swallow immunotherapy in children and adults
    • Andrè C, Vatrinet C, Galvain S,. Safety of sublingual swallow immunotherapy in children and adults. Int Arch Allergy Immunol. 2000; 121: 220-234.
    • (2000) Int Arch Allergy Immunol , vol.121 , pp. 220-234
    • Andrè, C.1    Vatrinet, C.2    Galvain, S.3
  • 74
    • 6344237121 scopus 로고    scopus 로고
    • Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real life: Clinical efficacy and more
    • Marogna M, Spadolini I, Massolo A., et al.Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real life: Clinical efficacy and more. Allergy. 2004; 50: 1205-1210
    • (2004) Allergy , vol.50 , pp. 1205-1210
    • Marogna, M.1    Spadolini, I.2    Massolo, A.3
  • 75
    • 3042788106 scopus 로고    scopus 로고
    • Quantitative assessment of the adherence to sublingual immunotherapy
    • Lombardi C, Gani F, Landi M., et al.Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol. 2004; 113: 1219-1220.
    • (2004) J Allergy Clin Immunol. , vol.113 , pp. 1219-1220
    • Lombardi, C.1    Gani, F.2    Landi, M.3
  • 76
    • 33646480799 scopus 로고    scopus 로고
    • Quantitative assessment of the compliance with once-daily sublingual immunotherapy regimen in real life (EASY project: Evaluation of A novel SLIT formulation during a Year
    • Passalacqua G, Musarra A, Pecora S., et al.Quantitative assessment of the compliance with once-daily sublingual immunotherapy regimen in real life (EASY project: Evaluation of A novel SLIT formulation during a Year. J Allergy Clin Immunol. 2006; 117: 946-948.
    • (2006) J Allergy Clin Immunol , vol.117 , pp. 946-948
    • Passalacqua, G.1    Musarra, A.2    Pecora, S.3
  • 77
    • 33846938383 scopus 로고    scopus 로고
    • Quantitative assessment of the compliance with once daily sublingual immunotherapy in children (EASY project: Evaluation of A novel SLIT formulation during a Year)
    • Passalacqua G, Musarra A, Pecora S., et al.Quantitative assessment of the compliance with once daily sublingual immunotherapy in children (EASY project: Evaluation of A novel SLIT formulation during a Year). Pediatr Allergy Immunol. 2007; 18: 56-62.
    • (2007) Pediatr Allergy Immunol , vol.18 , pp. 56-62
    • Passalacqua, G.1    Musarra, A.2    Pecora, S.3
  • 78
    • 28444463609 scopus 로고    scopus 로고
    • Children's compliance with allergen immunotherapy according to administration routes
    • Pajno G, Vita D, Caminiti L., et al.Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol. 2005; 116: 1380-1381.
    • (2005) J Allergy Clin Immunol , vol.116 , pp. 1380-1381
    • Pajno, G.1    Vita, D.2    Caminiti, L.3
  • 79
    • 70449090079 scopus 로고    scopus 로고
    • Adherence to sublingual immunotherapy: The allergist's viewpoint
    • Passalacqua G, Frati F, Puccinelli P., et al.Adherence to sublingual immunotherapy: The allergist's viewpoint. Allergy. 2009; 64: 1796-1797
    • (2009) Allergy , vol.64 , pp. 1796-1797
    • Passalacqua, G.1    Frati, F.2    Puccinelli, P.3
  • 80
    • 77956431823 scopus 로고    scopus 로고
    • Importance of patient's education in favouring compliance with sublingual immunotherapy
    • Incorvaia C, Rapetti A, Scurati S., et al.Importance of patient's education in favouring compliance with sublingual immunotherapy. Allergy. 2010; 65: 1341-1342.
    • (2010) Allergy. , vol.65 , pp. 1341-1342
    • Incorvaia, C.1    Rapetti, A.2    Scurati, S.3
  • 81
    • 77956431823 scopus 로고    scopus 로고
    • Importance of patient's education in favouring compliance with sublingual immunotherapy
    • Incorvaia C, Rapetti A, Scurati S., et al.Importance of patient's education in favouring compliance with sublingual immunotherapy. Allergy. 2010; 65: 1341-1342.
    • (2010) Allergy , vol.65 , pp. 1341-1342
    • Incorvaia, C.1    Rapetti, A.2    Scurati, S.3
  • 83
    • 79955364609 scopus 로고    scopus 로고
    • Role of immunmodulators in allergen-specific Immunotherapy
    • Kopp MV,. Role of immunmodulators in allergen-specific Immunotherapy. Allergy 2011; 66: 792-7.
    • (2011) Allergy , vol.66 , pp. 792-797
    • Kopp, M.V.1
  • 84
    • 79955473722 scopus 로고    scopus 로고
    • 100 years of hyposensitization: History of allergen-specific immunotherapy (ASIT)
    • Ring J, Gutermuth J,. 100 years of hyposensitization: History of allergen-specific immunotherapy (ASIT). Allergy 2011; 66: 713-24.
    • (2011) Allergy , vol.66 , pp. 713-724
    • Ring, J.1    Gutermuth, J.2
  • 85
    • 79955483371 scopus 로고    scopus 로고
    • Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens
    • Valenta R, Linhart B, Swoboda I,. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens. Allergy 2011; 66: 775-83.
    • (2011) Allergy , vol.66 , pp. 775-783
    • Valenta, R.1    Linhart, B.2    Swoboda, I.3
  • 86
    • 79955478697 scopus 로고    scopus 로고
    • Immunotherapy with peptides
    • Moldaver D, Larche M,. Immunotherapy with peptides. Allergy 2011; 66: 784-91.
    • (2011) Allergy , vol.66 , pp. 784-791
    • Moldaver, D.1    Larche, M.2
  • 87
    • 79960442732 scopus 로고    scopus 로고
    • Food allergy in children: Anything new in its management?
    • Wassenberg J, Hofer M, Perrin Y, et al. Food allergy in children: Anything new in its management?. Rev Med Suisse. 2011; 7 (295): 1108-12.
    • (2011) Rev Med Suisse , vol.7 , Issue.295 , pp. 1108-1112
    • Wassenberg, J.1    Hofer, M.2    Perrin, Y.3
  • 89
    • 78650853936 scopus 로고    scopus 로고
    • Single-tree nut immunotherapy attenuates allergic reactions in mice with hypersensitivity to multiple tree nuts
    • Kulis M, Li Y, Lane H, et al. Single-tree nut immunotherapy attenuates allergic reactions in mice with hypersensitivity to multiple tree nuts. J Allergy Clin Immunol. 2011; 127 (1): 81-8.
    • (2011) J Allergy Clin Immunol , vol.127 , Issue.1 , pp. 81-88
    • Kulis, M.1    Li, Y.2    Lane, H.3
  • 92
    • 79955466306 scopus 로고    scopus 로고
    • Epicutaneous allergen administration: Is this the future of allergen-specific immunotherapy?
    • Senti G, von Moos S, Kundig TM,. Epicutaneous allergen administration: Is this the future of allergen-specific immunotherapy? Allergy 2011; 66: 798-809.
    • (2011) Allergy , vol.66 , pp. 798-809
    • Senti, G.1    Von Moos, S.2    Kundig, T.M.3
  • 93
    • 3042788106 scopus 로고    scopus 로고
    • Quantitative assessment of the adherence to sublingual immunotherapy
    • Lombardi C, Gani F, Landi M., et al.Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol. 2004; 113: 1219-1220.
    • (2004) J Allergy Clin Immunol , vol.113 , pp. 1219-1220
    • Lombardi, C.1    Gani, F.2    Landi, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.